4
Shared Docs
4
Same-Page
4 / 4
Mentions
les now called Adverum Beledinolcoes 4120115 10000 398,606 25,000 25500 -373,108. BASF ADR 4/13/15 ‘000 508,056 466,450 476,350 -31,706 Bank of New York Mellon 6/25/14 250,000 9,076 406 12,755,000 - -9,076 408 Biogen Idec Inc 2/14/12 Z095 250,455 568,499 608.691 356,236 Bioverativ Inc 2/1/17
cost basis I • EFTA00811546 Purchase Quantity 6/30117 7131117 Unrealized Asset Description Date Cost Value Value Gain (Loss) . . — Haze Trust - Fixed income (DA)3,, -- JP Morgan Chase 7.9% Pfd 4/30/2049 JPM Tr Fit Rate Income Fund 05/10/11 01/22/13 3.000,000 240.973.957 3337.958 2.413,469
now called Adverum Biotechnologies 4/20/15 10.000 398,608 25,000 25,500 -373,106 BASF ADR 4/13/15 5,000 508,056 466,450 478,350 -31,706 Bank of New York Mellon 6/25/14 2561,000 12,755,000 - 0 Blogen Ides Inc 2/14/12 2.095 250.455 568,499 606,691 356238 Bioverativ Inc 2/1/17 1,047 20,254 62,9
538,973 51,691 135,985,107 EFTA00811554 Purchase Quantity 6/30/17 741117 Unrealized Gain (Lose) Asset Description Date Coet Value Value Haze Trust - Fixed Income (DB) JP Morgan Chase 7.9% Pfd 4/30/2049 05/10/11 3,000,000 3.337,958 3,158,000 3,112.500 -225,456 JPM Tr Pk Rate Income Fund 01/22/13
s now called Adverum Biotechnologies 4/20/15 10 000 398,606 25500 25,000 -373 606 -41,606 BASF ADR 4/13/15 5000 508,056 472,250 486,450 Bank of New York Mellon 6/25/14 2517,000 9,076,406 11,780,000 12,755,000 3,678594 318.044 Blogen Idec Inc 2/14/12 2,095 250.455 519.078 568,499 Bioverativ Inc
826,766 51,690 127,228,936 EFTA00811532 Purchase Quantity 5/31/17 6130117 Unrealized Asset Description Dab Cost Value Value Gain (Lose) Haze Trust - Fixed Income (DB) JP Morgan Chase 7.9% PM 4/30/2049 05/10/11 3,000300 3,337,958 3,133,150 3 -179,958 JPM Tr Fit Rate Income Fund 01/22/13 240.30339
now called Adverum Biotechnologies 4/20/15 10.000 398,608 25,000 25,500 -373,106 BASF ADR 4/13/15 5,000 508,056 466,450 478,350 -31,706 Bank of New York Mellon 6/25/14 2561,000 12,755,000 - 0 Blogen Ides Inc 2/14/12 2.095 250.455 568,499 606,691 356238 Bioverativ Inc 2/1/17 1,047 20,254 62,9
538,973 51,691 135,985,107 EFTA00617224 Purchase Quantity 6/30/17 741117 Unrealized Gain (Lose) Asset Description Date Coet Value Value Haze Trust - Fixed Income (DB) JP Morgan Chase 7.9% Pfd 4/30/2049 05/10/11 3,000,000 3.337,958 3,158,000 3,112.500 -225,456 JPM Tr Pk Rate Income Fund 01/22/13
Entities connected to both Bank of New York Mellon and Haze Trust - Fixed

Jeffrey Epstein
PERSON
Apple
ORGANIZATION
BNP Paribas
ORGANIZATIONGilead Sciences Inc
ORGANIZATION

Barclays
ORGANIZATIONBASF ADR
ORGANIZATIONFoundation Medicine Inc
ORGANIZATIONCredit Suisse Group
ORGANIZATION
Prince Charles
PERSONSouthern Trust Company
ORGANIZATIONSouthern Cal Edison
ORGANIZATIONSouthern Trust Co. - Equities
ORGANIZATIONJPM Trust
ORGANIZATION
Volkswagen AG
ORGANIZATIONSeaspan
LOCATIONCharles Schwab
PERSONSangamo Biosciences Inc
ORGANIZATION
JPMorgan Chase
ORGANIZATIONAscena Retail Group Inc.
ORGANIZATION